Robin Wagner
Responsable des Ressources Humaines chez KEROS THERAPEUTICS, INC.
Profil
Robin Wagner is currently the Vice President-Human Resources at Keros Therapeutics, Inc. Prior to this, Ms. Wagner worked as a Principal at Genzyme Therapeutics Ltd.
and Karyopharm Therapeutics, Inc. Ms. Wagner completed their undergraduate degree at the University of Hartford.
Postes actifs de Robin Wagner
| Sociétés | Poste | Début |
|---|---|---|
| KEROS THERAPEUTICS, INC. | Responsable des Ressources Humaines | 01/06/2021 |
Anciens postes connus de Robin Wagner
| Sociétés | Poste | Fin |
|---|---|---|
| KARYOPHARM THERAPEUTICS INC. | Corporate Officer/Principal | - |
Genzyme Therapeutics Ltd.
 Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Corporate Officer/Principal | - |
Formation de Robin Wagner
| University of Hartford | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 2 |
|---|---|
| KEROS THERAPEUTICS, INC. | Health Technology |
| KARYOPHARM THERAPEUTICS INC. | Health Technology |
| Entreprise privées | 1 |
|---|---|
Genzyme Therapeutics Ltd.
Genzyme Therapeutics Ltd. Pharmaceuticals: MajorHealth Technology Genzyme Therapeutics Ltd. develops transformative therapies for patients affected by rare and debilitating diseases. Its treatment areas include thyroid cancer, sclerosis, Fabry disease and Pompe. The company was founded on November 5, 2001 and is headquartered in Oxford, the United Kingdom. | Health Technology |
